Search

Your search keyword '"Xiao-Zhong Chen"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Xiao-Zhong Chen" Remove constraint Author: "Xiao-Zhong Chen"
76 results on '"Xiao-Zhong Chen"'

Search Results

1. Radiation dose escalation for locally advanced nasopharyngeal carcinoma patients with local and/or regional residual lesions after standard chemoradiotherapy: a non-randomized, observational study

2. Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyResearch in context

3. The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

4. Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update

5. Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma

6. Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma

7. Predictive Model and Precaution for Oral Mucositis During Chemo-Radiotherapy in Nasopharyngeal Carcinoma Patients

8. TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma

9. Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update

10. Oral Mucosa Dose Parameters Predicting Grade ≥3 Acute Toxicity in Locally Advanced Nasopharyngeal Carcinoma Patients Treated With Concurrent Intensity-Modulated Radiation Therapy and Chemotherapy: An Independent Validation Study Comparing Oral Cavity versus Mucosal Surface Contouring Techniques

11. ABO blood group is a predictor of survival in patients with laryngeal cancer

12. Metabolites Produced by the Endophytic Fungus Aspergillus fumigatus from the Stem of Erythrophloeum fordii Oliv.

14. Supplementary Table S5: Differentially Methylated CpG Sites (2173 Sites) in 24 NPC and 24 NCNBT from Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma

15. Supplimentary Figure S2: Kaplan-Meier curves estimation of DFS and OS for patients with high or low methylation levels stratified by tumor stage or the receipt of concurrent chemotherapy from Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma

16. Supplementary Tables S1-S7 and Supplementary Figure Legends from Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma

17. Supplementary Figure S1: Representative Pyrograms of Methylation Analysis by Bisulfite Pyrosequencing. from Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma

18. Radiation dose escalation for local advanced nasopharyngeal carcinoma patients with locally and/or regionally residual lesions after standard chemoradiotherapy

20. Apatinib in treating patients with recurrent or metastatic nasopharyngeal carcinoma who had failed prior platinum-based chemotherapy

21. Association between Cervical Lymph Node Metastasis and the Incidence of Radiation-Induced Hypothyroidism in Nasopharyngeal Carcinoma

22. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China

23. Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial

24. Identification of potent CypD inhibitors via pharmacophore based virtual screening, docking and molecular dynamics simulation

25. Insights into the structural requirements of PKCζ inhibitors as potential anti-arthritis agents based on 3D-QSAR, homology modeling and docking approach

26. Neoadjuvant chemotherapy with different dose regimens of docetaxel, cisplatin and fluorouracil (TPF) for locoregionally advanced nasopharyngeal carcinoma: a retrospective study

27. An evaluation of nutrition intervention during radiation therapy in patients with locoregionally advanced nasopharyngeal carcinoma

28. Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial

29. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

30. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma

31. Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: Development and validation of a predictive score model

32. Impact of dose volume parameters and clinical factors on acute radiation oral mucositis for locally advanced nasopharyngeal carcinoma patients treated with concurrent intensity-modulated radiation therapy and chemoradiotherapy

33. A Phase II Trial of Endostar Combined With Gemcitabine and Cisplatin Chemotherapy in Patients With Metastatic Nasopharyngeal Carcinoma (NCT01612286)

35. Radiotherapy for Adult Medulloblastoma: Evaluation of Helical Tomotherapy, Volumetric Intensity Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy and the Results of Helical Tomotherapy Therapy

36. [Chemical constituents from Pteris multifida and cytotoxic activity]

37. Bioactive quinolizidine alkaloids from Sophora tonkinensis

38. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

39. Novel GATA4 mutations in patients with congenital ventricular septal defects

40. High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma

41. Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma

42. Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

43. Bioactive lignans from Silybum marianum

44. Prevalence and spectrum of GATA5 mutations associated with congenital heart disease

45. Third-time coronary artery revascularisation: Results of 35 consecutive patients

46. A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect

47. Social Network Analyses based on e-portfolio assessment

48. A novel GATA4 mutation responsible for congenital ventricular septal defects

49. Novel NKX2-5 mutations in patients with familial atrial septal defects

50. [Study on cancer incidence through the cancer registry program in 11 cities and counties, China]

Catalog

Books, media, physical & digital resources